Literature DB >> 31361517

Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.

Rebecca B Hershow1, Michelle Gonzalez2, Elizabeth Costenbader3, William Zule4, Carol Golin5, Lauren Brinkley-Rubinstein6.   

Abstract

Despite high pre-exposure prophylaxis (PrEP) acceptability among people who inject drugs (PWID) and PrEP providers, PrEP uptake is low and little is known about how to promote PrEP among PWID. This qualitative study with providers in North Carolina explored views on PrEP delivery approaches for PWID. Interviewers conducted semistructured interviews with 10 PrEP providers and 10 harm reduction (HR) providers. Interviews were transcribed and analyzed. Many participants expressed acceptability for providing PrEP referrals at syringe exchange sites, stationing PrEP providers at syringe exchange sites to provide PrEP prescriptions, and providing standing orders for PrEP at syringe exchange sites. Barriers were identified, including low PrEP awareness and limited resources. Many advocated for co-location of HR and PrEP services and scaled-up outreach services. PrEP providers emphasized maintenance of clinical requirements, while HR providers emphasized flexibility when treating PWID. Promoting PrEP uptake and adherence among PWID likely requires integration of HR and PrEP services.

Entities:  

Keywords:  HIV prevention; intervention development; people who inject drugs; pre-exposure prophylaxis; qualitative research

Mesh：

Substances：

Year:  2019        PMID： 31361517      PMCID： PMC7289066          DOI： 10.1521/aeap.2019.31.4.363

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN： 0899-9546


  17 in total

1.  Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Authors:  E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock
Journal:  AIDS Behav       Date:  2017-04

2.  Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.

Authors:  Carla Treloar; Jake Rance; Kenneth Yates; Limin Mao
Journal:  Int J Drug Policy       Date:  2015-09-03

3.  An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users.

Authors:  Alexis M Roth; Brenna L Aumaier; Marisa A Felsher; Seth L Welles; Ana P Martinez-Donate; Martha Chavis; Barbara Van Der Pol
Journal:  Sex Transm Dis       Date:  2018-04       Impact factor: 2.830

4.  Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.

Authors:  Michael Martin; Suphak Vanichseni; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Benjamaporn Chaipung; Dararat Worrajittanon; Manoj Leethochawalit; Sithisat Chiamwongpaet; Somyot Kittimunkong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Timothy H Holtz; Taraz Samandari; Kachit Choopanya
Journal:  Lancet HIV       Date:  2016-11-18       Impact factor: 12.767

5.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

6.  Navigating identity, territorial stigma, and HIV care services in Vancouver, Canada: A qualitative study.

Authors:  Alexandra B Collins; Surita Parashar; Kalysha Closson; Rosalind Baltzer Turje; Carol Strike; Ryan McNeil
Journal:  Health Place       Date:  2016-06-21       Impact factor: 4.078

Review 7.  Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Authors:  Guthrie S Birkhead; Susan J Klein; Alma R Candelas; Daniel A O'Connell; Jeffrey R Rothman; Ira S Feldman; Dennis S Tsui; Richard A Cotroneo; Colleen A Flanigan
Journal:  Int J Drug Policy       Date:  2007-02-20

Review 8.  HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.

Authors:  Daniel J Escudero; Mark N Lurie; Thomas Kerr; Chanelle J Howe; Brandon D L Marshall
Journal:  J Int AIDS Soc       Date:  2014-03-27       Impact factor: 5.396

Review 9.  Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact.

Authors:  Carol Strike; Miroslav Miskovic
Journal:  Harm Reduct J       Date:  2018-02-08

10.  Implementation of a Rapid Entry Program Decreases Time to Viral Suppression Among Vulnerable Persons Living With HIV in the Southern United States.

Authors:  Jonathan Colasanti; Jeri Sumitani; C Christina Mehta; Yiran Zhang; Minh Ly Nguyen; Carlos Del Rio; Wendy S Armstrong
Journal:  Open Forum Infect Dis       Date:  2018-06-28       Impact factor: 3.835
View more
  7 in total

1.  Health Care Providers' Views on Clinic Infrastructure and Practice Models That May Facilitate HIV Preexposure Prophylaxis (PrEP) Prescribing: A Qualitative Meta-Synthesis.

Authors:  Yuko Mizuno; Deborah J Gelaude; Nicole Crepaz; Emiko Kamitani; Julia B DeLuca; Carolyn A Leighton; Megan E Wichser; Dawn K Smith
Journal:  Health Promot Pract       Date:  2021-09-22

2.  "I think everybody should take it if they're doing drugs, doing heroin, or having sex for money": a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program.

Authors:  Sarahmona M Przybyla; Catherine Cerulli; Jacob Bleasdale; Kennethea Wilson; Melissa Hordes; Nabila El-Bassel; Diane S Morse
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-11-23

3.  The Italian PrEPventHIV challenge: a scoping systematic review on HIV pre-exposure prophylaxis monitoring in Italy.

Authors:  Pietro Ferrara; Vincenza Gianfredi
Journal:  Acta Biomed       Date:  2022-07-01

4.  Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.

Authors:  Adrian R King; Saanchi Shah; Laura A Randall; Paula M Frew; Anne Spaulding; Ian W Holloway
Journal:  BMC Infect Dis       Date:  2022-09-14       Impact factor: 3.667

5.  Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: Nearly 40 years on.

Authors:  Sara Croxford; Eva Emanuel; Ammi Shah; Cuong Chau; Vivian Hope; Monica Desai; Samreen Ijaz; Justin Shute; Claire Edmundson; Ross J Harris; Valerie Delpech; Emily Phipps
Journal:  HIV Med       Date:  2022-03-30       Impact factor: 3.094

6.  Combination adherence strategy to support HIV antiretroviral therapy and pre-exposure prophylaxis adherence during pregnancy and breastfeeding: protocol for a pair of pilot randomised trials.

Authors:  Friday Saidi; Wilbroad Mutale; Kellie Freeborn; Nora E Rosenberg; Lauren Aiko Graybill; Suzanne Maman; K Rivet Amico; Katie R Mollan; Twambilile Phanga; Beteniko Milala; Lauren M Hill; Allison M Gottwalt; Sam Phiri; Thoko Kalua; Benjamin H Chi
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 2.692

7.  Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.

Authors:  Benedikt Pleuhs; Colleen B Mistler; Katherine G Quinn; Julia Dickson-Gomez; Jennifer L Walsh; Andrew E Petroll; Steven A John
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.